MiNK Therapeutics Inc. (INKT)
INKT trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$10.23
-2.85% on the day
Market cap
$52.2M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | INKT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001840229 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-11-07 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-08-13 |
| Latest proxy | DEF 14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 265 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BKHA | Black Hawk Acquisition Corporation | $12.48 | -4.00% | $51.8M |
| KLRS | Kalaris Therapeutics Inc. | $2.23 | -1.33% | $53.1M |
| ELOX | Eloxx Pharmaceuticals Inc. | $12.70 | -8.57% | $51.3M |
| CRBU | Caribou Biosciences Inc. | $0.4700 | -5.41% | $50.4M |
| IMA | ImageneBio Inc. | $4.24 | -0.23% | $48.1M |
| INMB | INmune Bio Inc. | $1.68 | -5.62% | $46.6M |
| LONA | LeonaBio Inc. | $6.43 | +4.30% | $60.6M |
| EXOZ | eXoZymes Inc. | $4.59 | -9.11% | $42.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier